Search research articles
Contact Us
Filters
Showing results (51-60 of 230) with videos related to
Page
of 23
Sort By:
Neuroscience and Biobehavioral Reviews
|
February 1, 2017
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication?
Carla Balia, Sara Carucci, David Coghill, et al.
JCPP Advances
|
March 12, 2026
A comprehensive longitudinal analysis of changes during Attention Deficit Hyperactive Disorder pharmacological treatments: Relationships between clinical measures, QbCheck and Conners CPT-II
Seungjae Lee, Renee Testa, Beth Johnson, et al.
Science Advances
|
June 14, 2023
Not so smart? "Smart" drugs increase the level but decrease the quality of cognitive effort
Elizabeth Bowman, David Coghill, Carsten Murawski, et al.
Current Psychiatry Reports
|
January 17, 2017
Prenatal Risk Factors and the Etiology of ADHD-Review of Existing Evidence
Emma Sciberras, Melissa Mulraney, Desiree Silva, et al.
Frontiers in Psychiatry
|
March 8, 2021
Disentangling ADHD's Presentation-Related Decision-Making-A Meta-Analytic Approach on Predominant Presentations
Marcel Schulze, David Coghill, Silke Lux, et al.
European Child & Adolescent Psychiatry
|
July 6, 2012
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
Paul Hodgkins, Monica Shaw, David Coghill, et al.
Journal of Consulting and Clinical Psychology
|
August 12, 2021
Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
Iris Merith E Idema, Jonathan M Payne, David Coghill
Journal of Child Psychology and Psychiatry, and Allied Disciplines
|
May 13, 2009
Practitioner review: Quality of life in child mental health--conceptual challenges and practical choices
David Coghill, Marina Danckaerts, Edmund Sonuga-Barke, et al.
The Lancet. Child & Adolescent Health
|
May 15, 2020
Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group
Samuele Cortese, David Coghill, Paramala Santosh, et al.
JAMA Network Open
|
July 22, 2022
Prevalence of Mental Health Problems in Transgender Children Aged 9 to 10 Years in the US, 2018
Douglas H Russell, Monsurul Hoq, David Coghill, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 230) with videos related to
Sort By:
Page
of 23
Neuroscience and Biobehavioral Reviews
|
February 1, 2017
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication?
Carla Balia, Sara Carucci, David Coghill, et al.
JCPP Advances
|
March 12, 2026
A comprehensive longitudinal analysis of changes during Attention Deficit Hyperactive Disorder pharmacological treatments: Relationships between clinical measures, QbCheck and Conners CPT-II
Seungjae Lee, Renee Testa, Beth Johnson, et al.
Science Advances
|
June 14, 2023
Not so smart? "Smart" drugs increase the level but decrease the quality of cognitive effort
Elizabeth Bowman, David Coghill, Carsten Murawski, et al.
Current Psychiatry Reports
|
January 17, 2017
Prenatal Risk Factors and the Etiology of ADHD-Review of Existing Evidence
Emma Sciberras, Melissa Mulraney, Desiree Silva, et al.
Frontiers in Psychiatry
|
March 8, 2021
Disentangling ADHD's Presentation-Related Decision-Making-A Meta-Analytic Approach on Predominant Presentations
Marcel Schulze, David Coghill, Silke Lux, et al.
European Child & Adolescent Psychiatry
|
July 6, 2012
Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
Paul Hodgkins, Monica Shaw, David Coghill, et al.
Journal of Consulting and Clinical Psychology
|
August 12, 2021
Effects of methylphenidate on cognitive functions in boys with attention deficit hyperactivity disorder: Does baseline performance matter?
Iris Merith E Idema, Jonathan M Payne, David Coghill
Journal of Child Psychology and Psychiatry, and Allied Disciplines
|
May 13, 2009
Practitioner review: Quality of life in child mental health--conceptual challenges and practical choices
David Coghill, Marina Danckaerts, Edmund Sonuga-Barke, et al.
The Lancet. Child & Adolescent Health
|
May 15, 2020
Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group
Samuele Cortese, David Coghill, Paramala Santosh, et al.
JAMA Network Open
|
July 22, 2022
Prevalence of Mental Health Problems in Transgender Children Aged 9 to 10 Years in the US, 2018
Douglas H Russell, Monsurul Hoq, David Coghill, et al.
Page
of 23